Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Post-Op Pain in Urogynecologic Surgery
NCT02287246Phase 4Unknown
- Sponsor
- Walter Reed National Military Medical Center
- Start
- Oct 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Walter Reed National Military Medical Center. Primary endpoint: Cumulative post-operative vaginal pain control at 3 days. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02287246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287246.